Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Lennernäs

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
Molecular Pharmaceutics|August 7, 2009
Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulationsHans Lennernäs
The Journal of Pharmacy and Pharmacology|June 14, 2003
Intestinal drug absorption and bioavailability: beyond involvement of single transport functionHans Lennernäs
Current Drug Metabolism|November 6, 2007
Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humansHans Lennernäs
Clinical Pharmacokinetics|October 9, 2003
Clinical pharmacokinetics of atorvastatinHans Lennernäs
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 31, 2013
Regional intestinal drug permeation: biopharmaceutics and drug developmentHans Lennernäs
Molecular Pharmaceutics|November 12, 2013
Human in vivo regional intestinal permeability: importance for pharmaceutical drug developmentHans Lennernäs
Advanced Drug Delivery Reviews|September 29, 2007
Animal data: the contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivoHans Lennernäs
Pharmaceutics|August 16, 2019
Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo ApproachesDavid Dahlgren, Hans Lennernäs
Drug Discovery Today. Technologies|July 2, 2014
Intestinal and blood-brain drug transport: beyond involvement of a single transport functionHans Lennernäs, Ebba Lundgren
Molecules (Basel, Switzerland)|June 25, 2020
Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery PerspectiveDavid Dahlgren, Hans Lennernäs
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
Molecular Pharmaceutics|August 7, 2009
Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulationsHans Lennernäs
The Journal of Pharmacy and Pharmacology|June 14, 2003
Intestinal drug absorption and bioavailability: beyond involvement of single transport functionHans Lennernäs
Current Drug Metabolism|November 6, 2007
Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humansHans Lennernäs
Clinical Pharmacokinetics|October 9, 2003
Clinical pharmacokinetics of atorvastatinHans Lennernäs
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 31, 2013
Regional intestinal drug permeation: biopharmaceutics and drug developmentHans Lennernäs
Molecular Pharmaceutics|November 12, 2013
Human in vivo regional intestinal permeability: importance for pharmaceutical drug developmentHans Lennernäs
Advanced Drug Delivery Reviews|September 29, 2007
Animal data: the contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivoHans Lennernäs
Pharmaceutics|August 16, 2019
Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo ApproachesDavid Dahlgren, Hans Lennernäs
Drug Discovery Today. Technologies|July 2, 2014
Intestinal and blood-brain drug transport: beyond involvement of a single transport functionHans Lennernäs, Ebba Lundgren
Molecules (Basel, Switzerland)|June 25, 2020
Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery PerspectiveDavid Dahlgren, Hans Lennernäs
Pageof 19